EMA/PE/0000220986 - paediatric investigation plan

tenapanor

Key facts

• Active substance:
  tenapanor
• Therapeutic area:
  Metabolism and nutrition disorders
• Decision number:
  EMA/PE/0000220986
• PIP number:
  EMA/PE/0000220986
• Pharmaceutical form(s):
  Coated tablet
• Condition(s) / indication(s):
  Treatment of hyperphosphataemia
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Compliance check done:
  No

Decision

EMA/PE/0000220986 : EMA decision of 6 December 2024 on the granting of a product specific waiver for tenapanor

Adopted Reference Number: EMADOC-1700519818-1793255 Corr